Hjem › Post-COVID-tilstander (lang-COVID) › Washington
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Washington
5 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i Washington.
Byer i Washington
Offisiell studietekst (engelsk)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Eastside Research Associates ( Site 3727), Redmond
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06667700A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Seattle Rheumatology Associates, Seattle
- Swedish Ambulatory Infusion Center- First Hill, Seattle
- Swedish Cancer Institute Treatment Center, Seattle
- og 6 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Swedish Medical Center, Seattle
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06631287A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Seattle
RekruttererFase 1
Alder 65 til 85 · Alle kjønn · Oppdatert 30. jun. 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Seattle Children's Hospital, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT03808922Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.